Herpetic Neuralgia News

FDA Approves Herpes Zoster Vaccine - Pharmacy Times



Medscape
 
FDA Approves Herpes Zoster Vaccine 
Pharmacy Times
... Shingrix demonstrated efficacy against shingles greater than 90% across all age groups, as well as sustained efficacy over a follow-up period of 4 years.2,3 By preventing shingles, Shingrix also reduced the overall incidence of postherpetic ...
FDA Approves Shingles Vaccine With More Than 90% Efficacy Managed Care magazine
FDA approves shingles vaccine Shingrix Healio
Shingles Vaccine Approved by FDA Contagionlive.com
StreetInsider.com  -Endpoints News 
all 40 news articles » 


Europe Post-Herpetic Neuralgia Market and Competitive Landscape 2017 - Research and Markets - Business Wire (press release)



Europe Post-Herpetic Neuralgia Market and Competitive Landscape 2017 - Research and Markets 
Business Wire (press release)
Europe Post-Herpetic Neuralgia Market and Competitive Landscape - 2017, provides comprehensive insights into Post-Herpetic Neuralgia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.

 


FDA approves a new vaccine for shingles that provides broad protection - STAT



STAT
 
FDA approves a new vaccine for shingles that provides broad protection 
STAT
The condition generally clears up within a few weeks. But some people who have had shingles go on to develop what's known as post-herpetic neuralgia, in which nerve pain persists for months and sometimes years. The risk of developing post-herpetic ...
New GlaxoSmithKline shingles vaccine gets FDA approval Philly.com
Shingrix approved in the US for prevention of shingles in adults aged 50 and over Markets Insider
Shingrix Gets FDA Go-Ahead MD Magazine
PR Newswire (press release)  -The Pharma Letter 
all 39 news articles » 


Why older adults need the shingles, flu and pneumonia vaccines - The Oakland Press



The Oakland Press
 
Why older adults need the shingles, flu and pneumonia vaccines 
The Oakland Press
Did you know that as you age, your immunity to the diseases you've been vaccinated against as a child starts to wane? That's why it's just as important to be vaccinated as an adult as it was as a child. Plus, some of the illnesses you could contract in ...

 


Cause of shingles pain discovered, paving the way for new treatments - Bel Marra Health



Bel Marra Health
 
Cause of shingles pain discovered, paving the way for new treatments 
Bel Marra Health
?Treatment for herpetic neuralgia is currently based on anti-inflammatory corticosteroids, which eliminate the symptoms but can impair control of the infection because they're immunosuppressants. Some of our findings suggest that therapies capable of ...

 


Acorda Therapeutics, Inc. (NASDAQ:ACOR) Closed 6.9% Above Its 50 Day Average - First News 24



Acorda Therapeutics, Inc. (NASDAQ:ACOR) Closed 6.9% Above Its 50 Day Average 
First News 24
The Company also markets Zanaflex Capsules and tablets, FDA-approved as short-acting drugs for the management of spasticity, and Qutenza, an FDA-approved dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia, ...

and more » 


Vertex Pharmaceuticals (VRTX) and Acorda Therapeutics (ACOR) Head to Head Analysis - Dispatch Tribunal



BZ Weekly
 
Vertex Pharmaceuticals (VRTX) and Acorda Therapeutics (ACOR) Head to Head Analysis 
Dispatch Tribunal
The Company also markets Zanaflex Capsules and tablets, FDA-approved as short-acting drugs for the management of spasticity, and Qutenza, an FDA-approved dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia, ...
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Closed 11.6% Above Its ... Modern Readers
Acorda Therapeutics, Inc. - ACOR - Stock Price Today - Zacks Zacks Investment Research

all 58 news articles » 


Restrictions on gabapentinoids causing 'fear and anxiety' among patients - Pulse



Pulse
 
Restrictions on gabapentinoids causing 'fear and anxiety' among patients 
Pulse
A Cochrane Review from June this year found that gabapentin 'can provide good levels of pain relief to some people with postherpetic neuralgia and peripheral diabetic neuropathy', but added that its effectiveness for other types of neuropathic pain 'is ...

and more » 


Shingles vaccine, Shingrix, receives approval in Canada - Outbreak ... - Outbreak News Today



Outbreak News Today
 
Shingles vaccine, Shingrix, receives approval in Canada - Outbreak ... 
Outbreak News Today
GlaxoSmithKline announced Friday that Shingrix has been approved in Canada for the prevention of shingles (herpes zoster) in people aged 50 years or older.

and more » 


ContraVir Pharmaceuticals Announces Research Collaboration ... - Nasdaq



ContraVir Pharmaceuticals Announces Research Collaboration ... 
Nasdaq
EDISON, N.J., Oct. 17, 2017-- ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of.

and more »